Oracle Siebel Core-Common Components up to 22.8 Calendar path traversal
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.4 | $0-$5k | 0.00 |
Summary
A vulnerability identified as critical has been detected in Oracle Siebel Core-Common Components up to 22.8. Impacted is an unknown function of the component Calendar. Performing a manipulation results in an unknown weakness. This vulnerability is cataloged as CVE-2022-24785. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability classified as critical has been found in Oracle Siebel Core-Common Components up to 22.8 (Customer Relationship Management System). This affects some unknown functionality of the component Calendar. CWE is classifying the issue as CWE-22. The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory. This is going to have an impact on integrity.
The weakness was shared 10/19/2022 as Oracle Critical Patch Update Advisory - October 2022. The advisory is shared at oracle.com. This vulnerability is uniquely identified as CVE-2022-24785. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1006 for this issue.
The vulnerability scanner Nessus provides a plugin with the ID 209237 (Atlassian Confluence 7.19.x < 7.19.26 (CONFSERVER-98190)), which helps to determine the existence of the flaw in a target environment.
A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at Tenable (209237) and EUVD (EUVD-2022-1677). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.5VulDB Meta Temp Score: 7.4
VulDB Base Score: 7.5
VulDB Temp Score: 7.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.5
NVD Vector: 🔍
CNA Base Score: 7.5
CNA Vector (GitHub, Inc.): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Path traversalCWE: CWE-22
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 209237
Nessus Name: Atlassian Confluence 7.19.x < 7.19.26 (CONFSERVER-98190)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Patch: github.com
Timeline
02/10/2022 🔍10/19/2022 🔍
10/19/2022 🔍
10/19/2022 🔍
03/31/2026 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - October 2022
Status: Confirmed
CVE: CVE-2022-24785 (🔍)
GCVE (CVE): GCVE-0-2022-24785
GCVE (VulDB): GCVE-100-211689
EUVD: 🔍
Entry
Created: 10/19/2022 08:30Updated: 03/31/2026 17:49
Changes: 10/19/2022 08:30 (38), 11/17/2022 14:52 (3), 11/17/2022 14:55 (20), 10/17/2024 20:48 (16), 11/04/2025 12:56 (11), 03/31/2026 17:49 (1)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.